Epidemiologic trends and distributions of imported infectious diseases among travelers to Japan before and during the COVID-19 pandemic, 2016 to 2021: a descriptive study.

COVID-19 epidemiology imported infectious disease surveillance travel

Journal

Journal of epidemiology
ISSN: 1349-9092
Titre abrégé: J Epidemiol
Pays: Japan
ID NLM: 9607688

Informations de publication

Date de publication:
17 Jun 2023
Historique:
medline: 19 6 2023
pubmed: 19 6 2023
entrez: 18 6 2023
Statut: aheadofprint

Résumé

Little is known about the trends of imported infectious diseases among travelers to non-endemic countries during the COVID-19 pandemic. This article aimed to describe those among travelers to Japan. This is a descriptive study based on national surveillance data. Imported infectious disease cases were defined as those with a reported overseas source of infection among 15 diseases pre-selected based on the probability and impact of importation. The number of notified cases from April 2016 to March 2021 were described by disease and time of diagnosis. The relative ratio and absolute difference in case counts-both by number and per arrival-were calculated by disease comparing those from the pandemic period (April 2020-March 2021) to the pre-pandemic period (April 2016-March 2020). A total of 3524 imported infectious disease cases were diagnosed during the study period, including 3439 cases before and 85 cases during the pandemic. The proportionate distribution of diseases changed but notification counts of all 15 diseases decreased during the pandemic. Accounting for arrivals, however, seven diseases showed a two-fold or greater increase, with a notable absolute increase per million arrivals for amebiasis (60.1; 95%CI, 41.5-78.7), malaria (21.7; 10.5-33.0), and typhoid fever (9.3; 1.9-16.8). The epidemiology of imported infectious diseases changed during the pandemic. While the number of imported infectious disease cases decreased, the number of cases per arrivals increased considerably both in relative and absolute terms for several diseases of public health and clinical importance.

Sections du résumé

BACKGROUND BACKGROUND
Little is known about the trends of imported infectious diseases among travelers to non-endemic countries during the COVID-19 pandemic. This article aimed to describe those among travelers to Japan.
METHODS METHODS
This is a descriptive study based on national surveillance data. Imported infectious disease cases were defined as those with a reported overseas source of infection among 15 diseases pre-selected based on the probability and impact of importation. The number of notified cases from April 2016 to March 2021 were described by disease and time of diagnosis. The relative ratio and absolute difference in case counts-both by number and per arrival-were calculated by disease comparing those from the pandemic period (April 2020-March 2021) to the pre-pandemic period (April 2016-March 2020).
RESULTS RESULTS
A total of 3524 imported infectious disease cases were diagnosed during the study period, including 3439 cases before and 85 cases during the pandemic. The proportionate distribution of diseases changed but notification counts of all 15 diseases decreased during the pandemic. Accounting for arrivals, however, seven diseases showed a two-fold or greater increase, with a notable absolute increase per million arrivals for amebiasis (60.1; 95%CI, 41.5-78.7), malaria (21.7; 10.5-33.0), and typhoid fever (9.3; 1.9-16.8).
CONCLUSION CONCLUSIONS
The epidemiology of imported infectious diseases changed during the pandemic. While the number of imported infectious disease cases decreased, the number of cases per arrivals increased considerably both in relative and absolute terms for several diseases of public health and clinical importance.

Identifiants

pubmed: 37331795
doi: 10.2188/jea.JE20230025
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ayu Kasamatsu (A)

Field Epidemiology Training Program, National Institute of Infectious Diseases.

Kazuhiko Kanou (K)

National Institute of Infectious Diseases.

Munehisa Fukusumi (M)

National Institute of Infectious Diseases.

Yuzo Arima (Y)

National Institute of Infectious Diseases.

Shun Omori (S)

Field Epidemiology Training Program, National Institute of Infectious Diseases.

Haruna Nakamura (H)

National Institute of Infectious Diseases.

Tetsuro Sato (T)

National Institute of Infectious Diseases.

Yusuke Serizawa (Y)

National Institute of Infectious Diseases.

Asuka Takeda (A)

National Institute of Infectious Diseases.

Hiroyuki Fujikura (H)

National Institute of Infectious Diseases.

Chiaki Ikenoue (C)

National Institute of Infectious Diseases.

Shingo Nishiki (S)

National Institute of Infectious Diseases.

Yoshihiro Fujiya (Y)

National Institute of Infectious Diseases.

Takeshi Arashiro (T)

National Institute of Infectious Diseases.

Takuri Takahashi (T)

National Institute of Infectious Diseases.

Tomoe Shimada (T)

National Institute of Infectious Diseases.

Motoi Suzuki (M)

National Institute of Infectious Diseases.

Tomimasa Sunagawa (T)

National Institute of Infectious Diseases.

Classifications MeSH